---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003232"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2025-04-08T23:59:59+00:00"
generated_at: "2026-05-23T18:58:04.806193+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma adopts 2025 Equity Incentive Plan with 1.5M initial shares

## Summary
- Plan effective March 31, 2025; shareholder approval required under Nasdaq rules.
- Initially authorizes 1,500,000 shares of common stock for awards.
- Annual increase on Jan 1 each year: 5% of outstanding shares, up to 2,500,000 per year (total cap 4,000,000).
- Plan expires March 31, 2035; awards can include options, SARs, restricted stock, RSUs, performance shares/units, cash.
- No specific officer/director grants announced; plan is broad-based for employees, consultants, directors.

## SEC filing metadata
- accession: 0001641172-25-003232
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2025-04-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000164117225003232/0001641172-25-003232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000164117225003232/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003232
- JSON: https://secwatch.observer/filing/0001641172-25-003232.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.